Medical News

RSS

Launch of The Oxford Genetics Knowledge Park by Matt Ridley

The Oxford Genetics Knowledge Park is a partnership between Oxford University and the Oxford Radcliffe Hospitals NHS Trust, and is one of six such Parks nationally, funded by the Departments of Health and Trade and Industry. The aim of the Genetics Knowledge Parks (GKPs) is to translate advances in genetics research into clinical practice.

6 Apr 2004

Call for sexual health policy to be driven by science instead of politics

Today three leading national public health organizations – the National Coalition of STD Directors (NCSD), the American Social Health Association (ASHA), and the National Family Planning & Reproductive Health Association (NFPRHA) – renewed their call for sexual health policy to be driven by science instead of politics.

6 Apr 2004

Phase 3 study of drug teduglutide in patients with short bowel syndrome

Teduglutide is an analog of glucagon-like peptide 2 (GLP-2), a naturally occurring hormone that regulates the growth, proliferation and maintenance of cells lining the gastrointestinal tract. Teduglutide has been shown in animal studies and previous human clinical trials to increase the size and number of these cells, thereby increasing the absorptive surface area of the intestines.

6 Apr 2004

Australian research shows that ginger prevents nausea or morning sickness when pregnant

In a new push to test the validity of complementary medicines, a randomised controlled trial of ginger as a treatment for nausea and vomiting during pregnancy has found that a dose of 1.05 gm of ginger a day does help to calm nausea and vomiting.

5 Apr 2004

Number of breaths given during CPR may be linked to survival

Researchers have identified a factor that may improve cardiac arrest survival rates according to a first-of-its-kind study of paramedic responses reported in today’s rapid access issue of Circulation: Journal of the American Heart Association.

5 Apr 2004

Fluorescent molecule used to examine real time chemical reactions that result in smooth-muscle contraction

Smooth muscle, found in the walls of blood vessels and in internal organs such as lungs, stomach and the bladder, contracts as the end result of a series of chemical reactions. In a new study, UT Southwestern researchers report that one set of chemical reactions resulting in the contraction of the smooth-muscle cells is augmented by a second chemical pathway that kicks in when the first pathway is limited.

5 Apr 2004

Women treated with radiation therapy to cure Wilms tumor can have healthy babies if entire pelvis was not irradiated

Women who were treated with radiation therapy to cure Wilms tumor as a child can go on to have healthy babies so long as their entire pelvis was not irradiated, according to a new study in the April 2004 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.

5 Apr 2004

Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy

Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy to reduce the risk of cancer in the opposite breast, according to the first large-scale study evaluating the impact of genetic counseling and testing on breast cancer treatment decisions.

5 Apr 2004

Collaboration to create a series of small molecule drugs leads against a Takeda target

Array BioPharma Inc. today announced the commencement of a drug discovery collaboration with Takeda Chemical Industries, Ltd. to create a series of small molecule drug leads against a Takeda target. This collaboration is in addition to Array's existing research agreement with Takeda that began in 2001.

5 Apr 2004

The National Cancer Institute has awarded USC scientists $3.5 million for a study of the enzyme that faithfully copies our genetic information

The National Cancer Institute has awarded USC scientists $3.5 million for a study of the enzyme that faithfully copies our genetic information, enabling it to pass from one generation to the next. The grant will fund structural, biochemical and computer studies designed to reveal how the enzyme, DNA polymerase, makes so few mistakes.

5 Apr 2004

The first human case of avian influenza A(H7) in British Columbia

The first human case of avian influenza A(H7) in British Columbia occurred in a person who was involved in culling of infected birds on 13-14 March. On 13 March, he may have been accidentally exposed in the eye. On 16 March, the individual reported conjunctivitis and nasal discharge. Treatment with oseltamavir, an antiviral drug active against influenza A viruses, began on 18 March. On 30 March, Health Canada concluded that this case was caused by avian influenza A(H7). Health Canada informed WHO of this case on 31 March. The patient's symptoms have fully resolved.

5 Apr 2004

Ohio university to get major expansion cancer program

The Ohio State University Board of Trustees today has authorized the preparation of architectural and engineering plans for a possible major expansion of the university’s cancer program.

5 Apr 2004

Research shows giving Tourette Syndrome patients the drug levodopa normalizes brain activity

Scientists have known for years that abnormal activity involving a brain chemical called dopamine is somehow connected to the movements and vocalizations, or tics, associated with Tourette syndrome. Now neuroscience researchers at Washington University School of Medicine in St. Louis have found brain activity in these patients is abnormal during memory tasks, as well.

5 Apr 2004

More evidence needed to link symptoms like tics or behavioral problems to a strep infection

Cephalosporins three times more effective than penicillin

Pediatricians treating a child who has strep throat should reconsider the role of penicillin given that a newer class of antibiotics called cephalosporins are three times more effective, according to a study being published in the April issue of Pediatrics. The findings will spark widespread debate, because they contradict long-established guidelines from the American Academy of Pediatrics, American Heart Association,and World Health Organization.

5 Apr 2004

ULTRACET® Effective And Well Tolerated For Post-Surgical Pain

A new study published in the latest edition of a leading medical journal has shown that treatment with ULTRACET® (37.5 mg tramadol hydrochloride/325 mg acetaminophen tablets) demonstrates similar efficacy and better tolerability than TYLENOL® with Codeine No. 3 when each is compared to placebo.

5 Apr 2004

NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent

NeoRx Corporation today announced that it has acquired from AnorMED Inc. the worldwide exclusive rights, excluding Japan, to develop, manufacture and commercialize AMD473, a platinum-based anti-cancer agent. AMD473 has been administered to more than 500 cancer patients in phase I and phase II clinical trials, demonstrating anti-cancer activity in a wide range of tumors and a manageable safety profile. NeoRx expects to initiate clinical studies of AMD473 in one or more cancer indications in the second half of this year.

5 Apr 2004

Penn State Hershey Medical Center awaits arrival of hospital's first sextuplets

The team of Penn State women's health obstetricians and Penn State Children's Hospital neonatologists at Penn State Milton S. Hershey Medical Center are preparing for the arrival of the first set of sextuplets in the medical center's 34-year history.

5 Apr 2004

A simple urine sample could soon be used to predict the complex toxic effects of new drugs

BlueGnome has pioneered the use of statistical signal modelling in the analysis of high throughput experimental data. Its first product BlueFuse for Microarrays uses statistical modelling techniques to eliminate Œnoise‚ generated in microarray experiments, enabling researchers to automatically identify the presence or absence of genes and proteins with a higher level of confidence than is currently possible.

5 Apr 2004

Implantable defibrillator cuts heart attack risk of sudden death by 31%

Researchers at Loyola University Health System, Maywood, Ill., and the University of Rochester Medical Center, Rochester, N.Y., found that the previously demonstrated survival benefit of ICDs following a heart attack can last up to 15 years.

5 Apr 2004

Medical News

Launch of The Oxford Genetics Knowledge Park by Matt Ridley

Call for sexual health policy to be driven by science instead of politics

Phase 3 study of drug teduglutide in patients with short bowel syndrome

Australian research shows that ginger prevents nausea or morning sickness when pregnant

Number of breaths given during CPR may be linked to survival

Fluorescent molecule used to examine real time chemical reactions that result in smooth-muscle contraction

Women treated with radiation therapy to cure Wilms tumor can have healthy babies if entire pelvis was not irradiated

Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy

Collaboration to create a series of small molecule drugs leads against a Takeda target

The National Cancer Institute has awarded USC scientists $3.5 million for a study of the enzyme that faithfully copies our genetic information

The first human case of avian influenza A(H7) in British Columbia

Ohio university to get major expansion cancer program

Research shows giving Tourette Syndrome patients the drug levodopa normalizes brain activity

More evidence needed to link symptoms like tics or behavioral problems to a strep infection

Cephalosporins three times more effective than penicillin

ULTRACET® Effective And Well Tolerated For Post-Surgical Pain

NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent

Penn State Hershey Medical Center awaits arrival of hospital's first sextuplets

A simple urine sample could soon be used to predict the complex toxic effects of new drugs

Implantable defibrillator cuts heart attack risk of sudden death by 31%

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Small solutions for big problems in drug discovery and delivery

Latest News